Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 23/05/2011
PIL Foradil

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 25/03/2011 and displayed until 23/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 01/03/2011 and displayed until 25/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 27/07/2010 and displayed until 01/03/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 08/06/2010 and displayed until 27/07/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 19/01/2007 and displayed until 08/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/01/2005 and displayed until 19/01/2007
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 12/08/2004 and displayed until 12/01/2005
Reasons for adding or updating:
  • Change to storage instructions
Updated on 02/03/2004 and displayed until 12/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 05/06/2003 and displayed until 02/03/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 21/12/2001 and displayed until 05/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 23/05/2001 and displayed until 21/12/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 17/11/2000 and displayed until 23/05/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   formoterol